{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:39:10Z","timestamp":1757309950923},"reference-count":61,"publisher":"Elsevier","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.pmbts.2019.01.006","type":"book-chapter","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T02:53:51Z","timestamp":1551840831000},"page":"307-319","source":"Crossref","is-referenced-by-count":7,"title":["Glycated albumin level is significantly decreased in patients suffering nephrotic syndrome"],"prefix":"10.1016","author":[{"given":"Zhe","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangqun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6383","key":"10.1016\/bs.pmbts.2019.01.006_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.01.006_bb0015","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.20720","article-title":"Albumin: biochemical properties and therapeutic potential","volume":"41","author":"Quinlan","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.01.006_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol Asp Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.01.006_bb0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.01.006_bb0030","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/0006-291X(68)90223-4","article-title":"Schiff base formation by the lysyl and hydroxylysyl side chains of collagen","volume":"33","author":"Page","year":"1968","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.01.006_bb0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10719-016-9694-y","article-title":"Pathways of the Maillard reaction under physiological conditions","volume":"33","author":"Henning","year":"2016","journal-title":"Glycoconj J"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.01.006_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/10408399409527667","article-title":"Chemistry of Amadori rearrangement products: analysis, synthesis, kinetics, reactions, and spectroscopic properties","volume":"34","author":"Yaylayan","year":"1994","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.01.006_bb0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1074-5521(01)00036-9","article-title":"Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement","volume":"8","author":"Venkatraman","year":"2001","journal-title":"Chem Biol"},{"key":"10.1016\/bs.pmbts.2019.01.006_bb0050","first-page":"43","article-title":"The Amadori product on protein: structure and reactions","volume":"304","author":"Baynes","year":"1989","journal-title":"Prog Clin Biol Res"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.01.006_bb0055","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1074\/jbc.M410973200","article-title":"Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity","volume":"280","author":"Ahmed","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2019.01.006_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cca.2013.07.013","article-title":"Review: glycation of human serum albumin","volume":"425","author":"Anguizola","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/bs.pmbts.2019.01.006_bb0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0076-6879(84)06010-9","article-title":"Nonenzymatic glucosylation of lysine residues in albumin","volume":"106","author":"Baynes","year":"1984","journal-title":"Methods Enzymol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.01.006_bb0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.abb.2003.08.012","article-title":"Intervention strategies to prevent pathogenetic effects of glycated albumin","volume":"419","author":"Cohen","year":"2003","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.01.006_bb0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0891-6632(88)80012-6","article-title":"Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy?","volume":"2","author":"Cohen","year":"1988","journal-title":"J Diabet Complicat"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.01.006_bb0080","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cca.2010.10.014","article-title":"Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia","volume":"412","author":"Koga","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.01.006_bb0085","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ki.2008.25","article-title":"Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis","volume":"73","author":"Peacock","year":"2008","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.01.006_bb0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2009.01.013","article-title":"Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects","volume":"84","author":"Koga","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.01.006_bb0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00592-009-0123-6","article-title":"Influence of iron metabolism indices on glycated haemoglobin but not glycated albumin levels in premenopausal women","volume":"47","author":"Koga","year":"2010","journal-title":"Acta Diabetol"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.01.006_bb0100","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/0004563218763695","article-title":"JGA (Japan Glycated Albumin) Study Group, Comparison of HbA1c and glycated albumin as a control marker for newborn complications in diabetic women in a multicentre study in Japan (Japan glycated albumin study group: study 2)","volume":"55","author":"Shimizu","year":"2018","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.01.006_bb0105","first-page":"977","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.01.006_bb0110","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/diab.44.8.968","article-title":"The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial","volume":"44","author":"Group CCT","year":"1995","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.01.006_bb0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.diabres.2008.04.012","article-title":"CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases","volume":"81","author":"Koga","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.01.006_bb0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cca.2014.03.001","article-title":"Glycated albumin; clinical usefulness","volume":"433","author":"Koga","year":"2014","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.01.006_bb0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/pedi.12013","article-title":"Evaluation of glycated hemoglobin and fetal hemoglobin-adjusted HbA1c measurements in infants","volume":"14","author":"Suzuki","year":"2013","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.01.006_bb0130","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s00125-011-2211-8","article-title":"Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus","volume":"54","author":"Suzuki","year":"2011","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.01.006_bb0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpeds.2008.01.024","article-title":"Inaccurate hemoglobin A(1C) levels in patients with type 1 diabetes and hereditary persistence of hemoglobin F","volume":"153","author":"Felner","year":"2008","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.01.006_bb0140","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1309\/YFVTUD0GHJF7D16H","article-title":"The effect of elevated fetal hemoglobin on hemoglobin A1c results: five common hemoglobin A1c methods compared with the IFCC reference method","volume":"129","author":"Rohlfing","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.01.006_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12291-010-0076-0","article-title":"Diagnostic dilemma of HbA1c detection in presence of a hemoglobinopathy: a case report","volume":"26","author":"Bhat","year":"2011","journal-title":"Indian J Clin Biochem"},{"issue":"Pt 5","key":"10.1016\/bs.pmbts.2019.01.006_bb0150","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1258\/acb.2012.011192","article-title":"Classification of variant forms of haemoglobin according to the ratio of glycated haemoglobin to glycated albumin","volume":"49","author":"Miyazaki","year":"2012","journal-title":"Ann Clin Biochem"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.01.006_bb0155","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-148-12-200806170-00221","article-title":"Systematic review: hydroxyurea for the treatment of adults with sickle cell disease","volume":"148","author":"Lanzkron","year":"2008","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.01.006_bb0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.2011.08916.x","article-title":"Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin","volume":"156","author":"Ngo","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/bs.pmbts.2019.01.006_bb0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cca.2013.06.011","article-title":"Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing's syndrome","volume":"424","author":"Kitamura","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.01.006_bb0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000337914","article-title":"Glycated albumin in patients with neonatal diabetes mellitus is apparently low in relation to glycemia compared with that in patients with type 1 diabetes mellitus","volume":"77","author":"Suzuki","year":"2012","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.01.006_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1399-5448.2012.00895.x","article-title":"Glycated albumin is lower in infants than in adults and correlated with both age and serum albumin","volume":"14","author":"Suzuki","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/bs.pmbts.2019.01.006_bb0180","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.saa.2015.01.120","article-title":"Effects of non-enzymatic glycation in human serum albumin. Spectroscopic analysis","volume":"152","author":"Szkudlarek","year":"2015","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.01.006_bb0185","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1177\/193229680800200620","article-title":"A review of glycated albumin as an intermediate glycation index for controlling diabetes","volume":"2","author":"Roohk","year":"2008","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.01.006_bb0190","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0022-1759(89)90275-5","article-title":"Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA","volume":"122","author":"Cohen","year":"1989","journal-title":"J Immunol Methods"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.01.006_bb0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpba.2012.01.004","article-title":"Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments","volume":"69","author":"Hage","year":"2012","journal-title":"J Pharm Biomed Anal"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2019.01.006_bb0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0021-9673(92)80120-J","article-title":"High-performance affinity chromatography system for the rapid, efficient assay of glycated albumin","volume":"597","author":"Yasukawa","year":"1992","journal-title":"J Chromatogr"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.01.006_bb0205","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/clinchem\/44.2.256","article-title":"Determination of glycated albumin by enzyme-linked boronate immunoassay (ELBIA)","volume":"44","author":"Ikeda","year":"1998","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.01.006_bb0210","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1073\/pnas.76.9.4258","article-title":"Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus","volume":"76","author":"Guthrow","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"10.1016\/bs.pmbts.2019.01.006_bb0215","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.clinbiochem.2007.08.001","article-title":"Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma","volume":"40","author":"Paroni","year":"2007","journal-title":"Clin Biochem"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.01.006_bb0220","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1177\/193229681100500619","article-title":"Basic performance of an enzymatic method for glycated albumin and reference range determination","volume":"5","author":"Kohzuma","year":"2011","journal-title":"J Diabetes Sci Technol"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.01.006_bb0225","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/1869","article-title":"Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites","volume":"5","author":"Curry","year":"1998","journal-title":"Nat Struct Biol"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.01.006_bb0230","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0009-9120(94)90034-5","article-title":"Semiautomated determination of glycated albumin in glycaemic control of diabetic patients","volume":"27","author":"Cabre","year":"1994","journal-title":"Clin Biochem"},{"issue":"Pt 2","key":"10.1016\/bs.pmbts.2019.01.006_bb0235","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/000456328602300210","article-title":"Glycosylated plasma protein measurement by a semi-automated method","volume":"23","author":"Moore","year":"1986","journal-title":"Ann Clin Biochem"},{"issue":"19\u201320","key":"10.1016\/bs.pmbts.2019.01.006_bb0240","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.cca.2012.04.025","article-title":"Glycated albumin in diabetic patients with chronic kidney disease","volume":"413","author":"Zheng","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.01.006_bb0245","first-page":"446","article-title":"Quantification of nonenzymically glycated albumin and total serum protein by affinity chromatography","volume":"30","author":"Yatscott","year":"1984","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.01.006_bb0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03256353","article-title":"Lucica GA-L glycated albumin assay kit: a new diagnostic test for diabetes mellitus","volume":"14","author":"Kohzuma","year":"2010","journal-title":"Mol Diagn Ther"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2019.01.006_bb0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-8981(02)00207-3","article-title":"An enzymatic method for the measurement of glycated albumin in biological samples","volume":"324","author":"Kouzuma","year":"2002","journal-title":"Clin Chim Acta"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.01.006_bb0260","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1373\/clinchem.2005.053447","article-title":"Development of an automated enzymatic assay for the determination of glycated serum protein in human serum","volume":"51","author":"Wang","year":"2005","journal-title":"Clin Chem"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2019.01.006_bb0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0009-8981(99)00158-8","article-title":"Reduction of reaction differences between human mercaptalbumin and human nonmercaptalbumin measured by the bromcresol purple method","volume":"289","author":"Muramoto","year":"1999","journal-title":"Clin Chim Acta"},{"key":"10.1016\/bs.pmbts.2019.01.006_bb0270","series-title":"Global Report on Diabetes","author":"Organization WH","year":"2016"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.01.006_bb0275","first-page":"15","article-title":"Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization","volume":"14","author":"Young","year":"2008","journal-title":"Am J Manag Care"},{"issue":"Suppl 1","key":"10.1016\/bs.pmbts.2019.01.006_bb0280","first-page":"S5","article-title":"Executive summary: standards of medical care in diabetes\u20142014","volume":"37","author":"Association AD","year":"2014","journal-title":"Chin J Diabetes"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.01.006_bb0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2169\/internalmedicine.50.4129","article-title":"Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease","volume":"50","author":"Okada","year":"2011","journal-title":"Intern Med"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2019.01.006_bb0290","first-page":"101","article-title":"CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases","volume":"191","author":"Koga","year":"1990","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.01.006_bb0295","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.diabres.2005.07.008","article-title":"Glycated albumin is low in obese, non-diabetic children","volume":"71","author":"Nishimura","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.01.006_bb0300","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1507\/endocrj.K05-137","article-title":"Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients","volume":"53","author":"Koga","year":"2006","journal-title":"Endocr J"},{"key":"10.1016\/bs.pmbts.2019.01.006_bb0305","series-title":"Poor Nutritional Status And Inflammation: Serum Albumin: Relationship to Inflammation and Nutrition","author":"Don","year":"2004"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.01.006_bb0310","first-page":"36","article-title":"Nephrotic syndrome in adults","volume":"17","author":"Mahalingasivam","year":"2018","journal-title":"Acute Med"}],"container-title":["Progress in Molecular Biology and Translational Science","Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117319300171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117319300171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T07:49:55Z","timestamp":1606636195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117319300171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":61,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2019.01.006","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}